![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 489/08 | (2006.01) |
A61K 31/485 | (2006.01) | ||
A61P 25/32 | (2006.01) |
(11) | Number of the document | 2307420 |
(13) | Kind of document | T |
(96) | European patent application number | 09734161.4 |
Date of filing the European patent application | 2009-04-23 | |
(97) | Date of publication of the European application | 2011-04-13 |
(45) | Date of publication and mention of the grant of the patent | 2011-11-30 |
(46) | Date of publication of the claims translation | 2012-03-26 |
(86) | Number | PCT/EP2009/054875 |
Date | 2009-04-23 |
(87) | Number | WO 2009/130270 |
Date | 2009-10-29 |
(30) | Number | Date | Country code |
08155092 | 2008-04-24 | EP |
(72) |
GUILLAUME, Michel, Joseph, Maurice, André, BE
GAEKENS, Tim, BE
|
(73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Nalmefeno di-esterio provaistai |
NALMEFENE DI-ESTER PRODRUGS |
Payment date | Validity (years) | Amount | |
2022-03-08 | 14 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2023-04-23 |